NCT05947474 2026-02-10
ORB
Orionis Biosciences Inc
Phase 1 Active not recruiting
Clinical Trials
5 trialsNCT07265921 2025-12-05
Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT07123415 2025-11-19
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Aptabio Therapeutics, Inc.
Phase 1 Recruiting
NCT07196579 2025-09-29
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
TCRx Therapeutics Co.Ltd
Phase 1 Not yet recruiting
NCT04877717 2025-03-25
A Study of SHR-A1904 in Patients With Advanced Solid Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1 Active not recruiting